Financial Year |
March 31 2023 |
Monetary Funds |
2,279,825,888.91 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
1,450,000.00 |
Accounts Receivable |
1,435,141,386.97 |
Advances to Suppliers |
22,081,613.57 |
Other Receivables |
33,592,439.85 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
182,615,341.06 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
4,083,912.54 |
Other Current Assets |
799,797,290.03 |
Total Current Assets |
5,027,691,209.79 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
186,637,779.79 |
Long-term Equity Investment |
405,460,482.86 |
Investment Properties |
107,972,338.84 |
Fixed Assetes |
1,642,696,312.37 |
Under-construction Projects |
411,628,899.64 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
12,677,715,692.57 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
37,369,744.46 |
Deferred Income Tax Assets |
241,387,324.37 |
Other Non-Current Assets |
124,840,236.84 |
Sub-Total of Non-Current Assets |
16,016,005,008.11 |
Total Assets |
21,043,696,217.90 |
Short-Term Loans |
643,407,888.02 |
Trading Financial liabilities |
-- |
Notes Payable |
55,634,876.35 |
Accounts Payable |
1,251,944,301.19 |
Accounts Received In Advance |
6,731,110.64 |
Employee Compensation Payable |
40,526,096.38 |
Taxes Payable |
127,028,020.03 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
200,403,639.45 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
392,664,895.41 |
Other Current Liabilities |
150,000.00 |
Sub-Total of Current Liabilities |
2,755,735,455.05 |
Long-term Loans |
3,794,926,886.84 |
Bonds Payable |
1,370,588,891.22 |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
1,411,238,793.39 |
Deferred Income Tax Liabilities |
261,682,350.61 |
Other Non-Current Liabilities |
15,752,730.00 |
Sub-Total of Non-Current Liabilities |
7,230,628,531.25 |
Total Liabilities |
9,986,363,986.30 |
Paid-In Capital(Or Share Stock) |
1,694,213,520.00 |
Capital Surplus |
1,121,205,704.58 |
Surplus Reserve |
489,507,065.16 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
6,396,447,518.61 |
Minority Stockholder's Interest |
1,261,777,952.03 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,795,554,279.57 |
Owner's Equity(Stockholder's Equity) |
11,057,332,231.60 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
21,043,696,217.90 |